Week 4: Medicare Part D Creditable Coverage and the $2,000 OOP Cap

Medicare Part D is entering uncharted territory.

For nearly two decades, the program has been relatively stable — steady premiums, broad plan choices, and predictable rules for employers. That stability is now being shaken.

Beginning in 2025, Part D introduced a $2,000 annual out-of-pocket cap on prescription drug costs. For consumers, this looks like long-awaited relief. For employers and advisors, it creates an entirely new compliance landscape.

Why does this matter?

Because what was creditable yesterday may not be creditable tomorrow. And with new employer rules kicking in by 2026, advisors and HR teams need to act now to avoid compliance gaps and costly penalties.

This is the biggest shake-up Part D has seen since it launched in 2006 — and the ripple effects will touch consumers, carriers, employers, and advisors alike.

Medicare Part D is the federal program that provides outpatient prescription drug coverage to Medicare beneficiaries.

Introduced in 2006, it filled a major gap in Medicare by covering prescriptions that seniors once had to pay for entirely out of pocket.

Part D plans are delivered through private insurers approved by Medicare.

Beneficiaries can enroll in a standalone drug plan (PDP) alongside Original Medicare or choose a Medicare Advantage plan (MAPD) that bundles medical and drug benefits. This flexibility made Part D an immediate success — today more than 50 million Americans are enrolled.

For seniors, Part D is often the difference between staying on life-saving medications and going without.

But the program’s influence goes further.

Every employer plan with prescription benefits is judged against it to determine whether that coverage is “creditable.” If it isn’t, employees who delay enrolling in Part D can face permanent lifetime penalties.

That’s why Part D matters not just for retirees, but also for employers, HR teams, and advisors. Each year they must evaluate their plan against Medicare’s standard, communicate its status to employees, and report it to CMS.

In short, Part D isn’t just another federal program — it sets the benchmark for drug coverage nationwide.

Eligibility for Medicare Part D begins when a person first becomes entitled to Medicare.

That usually means turning 65, but it can also occur earlier for individuals under 65 who qualify due to disability, End-Stage Renal Disease (ESRD), or ALS.

Timing is critical.

Most people have a seven-month Initial Enrollment Period (IEP) — beginning three months before the month they turn 65 and ending three months after. Outside this window, enrollment is limited to the annual Medicare Open Enrollment Period (October 15 – December 7) or certain Special Enrollment Periods.

Missing the IEP or relying on non-creditable coverage can trigger a permanent late-enrollment penalty. The penalty is calculated as 1% of the national base premium for every month without creditable coverage — and it lasts a lifetime.

That’s why employers’ annual creditable coverage notices matter.

Employees approaching Medicare eligibility need to know whether their workplace drug coverage “counts” so they can avoid unnecessary penalties. For advisors, reinforcing these deadlines and rules is one of the most valuable services you can provide.

For nearly 20 years, Medicare Part D offered beneficiaries a wide range of plan options at relatively modest cost.

Premiums stayed fairly flat, with the average hovering around $30–$35 per month for most of the program’s history. In fact, Part D was often considered one of Medicare’s most affordable and stable benefits.

That picture is changing.

With the introduction of the new $2,000 annual out-of-pocket cap, carriers are facing higher projected claims costs. In response, many are raising premiums sharply, trimming back formularies, or restructuring plan designs. Some plans that were $20–$30 a month in 2024 have jumped to $50, $60, or more in 2025 — in some cases, doubling in a single year. That kind of increase is unprecedented in the program’s history.

CMS has also given carriers more flexibility to raise premiums over the next few years: for 2025, plans could increase prices by as much as $35 per member per month. In 2026, that allowance will grow even further. This means beneficiaries may see continued premium pressure even after the cap is fully phased in.

At the same time, consumers still have many options to choose from.

• Part D options range from basic, lower-premium plans with limited formularies to enhanced plans with broader coverage and higher monthly costs.
• For those with limited incomes, Extra Help (the Low-Income Subsidy) is available to reduce or even eliminate premiums and copays.

The bottom line is that while the new cap offers welcome protection against catastrophic out-of-pocket costs, affordability is becoming a new concern.

Beneficiaries who once focused mainly on which drugs were covered now also have to weigh significant differences in monthly premium costs — making plan comparisons, and the guidance of experienced advisors, more important than ever.

For employers and advisors, rising premiums and shifting formularies don’t just affect retirees — they also make creditable coverage determinations harder for group health plans.

Starting in 2025, Medicare Part D beneficiaries will see something they’ve never had before — a hard cap on annual out-of-pocket prescription costs.

No matter how expensive their medications, spending will stop at $2,000 per year. On paper, this looks like the most consumer-friendly change in the program’s nearly 20-year history.

The Promise

• Predictability: For the first time, beneficiaries know their worst-case scenario upfront. No more open-ended exposure to thousands of dollars in drug costs.
• Relief for high-cost users: Seniors who take costly specialty drugs could save thousands. Someone spending $8,000 annually on prescriptions will now stop paying after $2,000.
• Better adherence: With less fear of catastrophic drug bills, more people are likely to stay on their medications instead of rationing or skipping doses.

The Reality

But in health care, there’s no such thing as a free lunch. To cover the cost of this protection, carriers are already responding in ways that may lessen the benefit:

• Premium increases: In 2025, some standalone Part D plans raised monthly premiums by up to $35, the maximum increase allowed under the new premium stabilization demonstration (KFF). In 2026, that cap grows higher, with increases of up to $50/month expected for some plans (KFF Health News).
• Base premium trending up: The Part D base beneficiary premium — a benchmark tied to overall program costs — will rise from about $36.78 in 2025 to $38.99 in 2026, roughly a 6% jump (Policy Engineer).
• Affordability concerns: For nearly two decades, Part D premiums stayed relatively stable. Now, with larger allowable increases, some plans have doubled in cost within a single year — a dramatic shift for seniors on fixed incomes.
• Other cost-shifting: Deductibles are rising too (from $590 in 2025 to $615 in 2026), and many carriers are trimming formularies or shifting drugs to higher cost tiers, meaning consumers may pay more out of pocket even before hitting the cap (UnitedHealthcare).

The bottom line:

While the $2,000 cap offers meaningful protection for those with the highest drug costs, it also signals the end of an unusually stable era in Part D pricing. For many beneficiaries, the trade-off may feel less like a win and more like a reshuffling of costs.

For employers, this richer Part D benefit means the bar for creditable coverage is moving higher — and the calculations are about to get more complex.

Medicare Part D isn’t just a retiree issue — it’s a compliance issue for every employer that offers prescription drug coverage.

Federal law requires employers to determine each year whether their plan is “creditable” compared to Part D. In plain English, that means asking: does our plan pay, on average, as much as Medicare’s drug benefit?

Why it matters:

If an employer incorrectly says a plan is creditable — or fails to provide notice at all — Medicare-eligible employees and dependents could face a lifetime late-enrollment penalty when they eventually sign up for Part D. That’s not only a compliance failure; it’s a serious employee-relations problem.

Employer responsibilities each year include:

• Testing the plan: Using the simplified method (while available) or an actuarial test to confirm whether coverage is creditable.
• Notifying employees and dependents: Delivering a written notice by October 15 each year, and upon request, stating whether the plan is creditable.
• Reporting to CMS: Filing the online disclosure form within 60 days of the start of the plan year, within 30 days of termination, or upon a plan change.
• Maintaining records: Keeping documentation in case of a CMS audit or employee dispute.

What’s changing:

Until now, many employers leaned on the shortcut method, assuming their coverage would pass. But starting in 2026, the compliance bar rises — and by 2027, the old shortcut will be limited further. Employers who keep treating this as a box-checking exercise risk getting caught off guard.

The takeaway:

Medicare Part D compliance is no longer “set it and forget it.” Employers need to verify their status with more rigor, communicate it clearly to employees, and document everything. Advisors who can help navigate these steps will be invaluable partners in the years ahead.

At its core, creditable coverage means that an employer’s prescription drug benefit is expected to be at least as generous, on average, as the standard Medicare Part D plan.

The determination is not about whether a single employee would do better under one plan or the other — it’s about how the plan pays overall compared to Part D.

Why it matters:

Employees and retirees who stay on non-creditable coverage without realizing it may face permanent late-enrollment penalties if they later join Part D. That’s why the government requires employers to test their coverage each year, notify employees, and file a disclosure with CMS.

What’s changing:

For years, determining creditable coverage was relatively simple. Employers could often rely on a “safe harbor” shortcut: if their plan met certain thresholds (like covering brand and generic drugs), it was deemed creditable without a detailed actuarial analysis. That shortcut is narrowing.

Beginning in 2026, employers will face a higher compliance bar because of the new $2,000 annual out-of-pocket cap in Medicare Part D. As Part D becomes more generous, many employer plans that were once creditable may no longer meet the standard. And by 2027, employers will need to use the revised simplified method or obtain a full actuarial equivalence test to confirm status.

The bigger picture:

This shift reflects a larger trend: Medicare Part D is evolving into a more robust, consumer-friendly program. That’s good news for seniors, but it creates new compliance challenges for employers. Plans that once easily passed the test may now fall short, and assumptions that “what worked before still works now” could prove costly.

The takeaway:

Creditable coverage is no longer just a box-check. It’s a moving target, tied to Medicare’s changing benefit design. Employers and advisors must update how they test and certify coverage if they want to avoid penalties — for themselves and for their employees.

2026 Is a Transition Year

The introduction of the $2,000 out-of-pocket cap has changed the math on what counts as “creditable coverage.” Plans that once passed easily under the old rules may now fall short. That makes 2026 a critical transition year for employers and advisors.

Two Options for 2026

For calendar year 2026, CMS will still allow employers to use either:

1. The legacy simplified determination (60% test): The long-standing shortcut method, where a plan qualifies as creditable if it’s expected to cover at least 60% of participants’ prescription costs. This option remains available for 2026 only.
2. The revised simplified determination (72% test): A new, stricter method introduced by CMS to reflect the richer Part D standard benefit under the Inflation Reduction Act. Plans must now cover closer to three-quarters of expected costs to qualify.

After 2026: One Shortcut Goes Away

Beginning January 1, 2027, the 60% shortcut will no longer be permitted. At that point, employers will need to rely on either:

• The revised simplified determination (72% test), or
• A full actuarial equivalence test conducted by an actuary.

This raises the bar for compliance. Many plans that squeaked by under the 60% method will not pass the 72% threshold — forcing employers to either adjust plan design or obtain actuarial certification.

What Employers Should Be Doing Now

• For 2025: Confirm whether your current plan still qualifies under the old 60% method (as normal). If it’s borderline, don’t wait — start testing under the 72% threshold to see if it will be considered creditable.
• For 2026: Decide which method you’ll use. If the plan won’t pass at 72%, you still have another year, but you may want to budget for actuarial testing or explore plan design changes (or be ok with offering non-creditable coverage).
• For 2027 and beyond: Prepare for the permanent phase-out of the 60% shortcut. Employers will need actuarial support unless they’re confident their plan meets the new 72% benchmark.

The bottom line:

2026 is the year employers lose the “easy button.” The new rules demand more rigorous testing, more documentation, and closer coordination with carriers, actuaries, or TPAs to avoid compliance gaps.

One of the biggest concerns for employers right now is whether carriers will step up and provide creditable coverage determinations — or leave employers on their own.

Unfortunately, the answer isn’t consistent across the industry.

Inconsistent Carrier Practices

Some insurers automatically provide employers with a creditable coverage status each year, often in the form of a written notice or statement. Others are silent, putting the compliance burden squarely on the employer. For small and mid-sized groups that may not have actuarial support, this inconsistency creates real risk. A plan could appear generous but still fail the actuarial test under the new rules, and the employer might not know it until it’s too late.

Why Carriers May Hold Back

Carriers are cautious because creditable coverage determinations are ultimately a regulatory certification. If a carrier misstates a plan’s status and an employee later faces a late-enrollment penalty, liability questions could follow. For that reason, many insurers prefer to avoid taking responsibility, leaving employers to seek their own actuarial confirmation.

The Role of Advisors and TPAs

When carriers don’t provide determinations, employers usually turn to their benefits advisor, actuary, or a third-party administrator (TPA). TPAs and actuarial firms can run the tests, prepare the required notices, and file disclosures with CMS. While this adds an extra step — and cost — it can also ensure the employer’s documentation is defensible if ever challenged.

Best Practice for Employers

Employers shouldn’t assume that silence from the carrier means compliance. Each year, they should:

• Ask the carrier directly if they will provide a creditable coverage determination for the plan.
• If the carrier won’t, engage an advisor or TPA early — well before the October 15 notice deadline — to run the test and prepare notices.
• Keep written records of the determination and the notices provided to employees and CMS.

In short, carriers can help employers stay compliant — but many won’t.

Employers that rely solely on their insurer’s word may be taking an unnecessary gamble. A proactive approach with advisors or TPAs is usually the safer path.

Failing to get creditable coverage right isn’t just a technical mistake — it carries real financial and compliance risks for both employers and employees.

Penalties for Employers

Employers are required by law to provide a written notice of creditable or non-creditable coverage each year to all Medicare-eligible employees and dependents, as well as report the plan’s status to CMS. Under 42 CFR §423.56, failure to comply can lead to:

• Regulatory consequences: CMS can treat non-compliance as a violation of federal notice and disclosure rules, exposing employers to audits or enforcement actions.
• Liability exposure: If an employer fails to notify an employee (or provides inaccurate information) and the employee incurs a lifetime late-enrollment penalty, the employer could face legal claims. Employees who believe they were misled may pursue damages for the financial harm caused.
• Reputational risk: For smaller groups especially, one misstep can erode employee trust and damage the employer’s credibility as a benefits sponsor.

Risks for Employees

The consequences for employees are more immediate and severe:

• Permanent late-enrollment penalty: If an employee relies on coverage that turns out not to be creditable, they’ll pay a lifetime penalty on their Part D premium — an extra 1% of the “national base premium” for every month they went without creditable coverage.
• Compounding costs: Since the penalty is permanent, even a short gap (say 12 months) adds 12% to every Part D premium they pay for the rest of their life. Over decades, that’s thousands of dollars lost.

Why Accuracy Matters

Because the stakes are so high for employees, employers can’t treat this as a “check the box” task. Incorrect or missing notices not only create compliance exposure, they can have lasting financial consequences for workers and retirees. That’s why advisors and TPAs often recommend keeping detailed documentation of:

• The methodology used to determine creditable coverage.
• The exact notices sent to employees (with proof of distribution).
• The disclosure filed with CMS.

In short:

The government may not issue a headline-grabbing fine for a missed notice, but the real penalty comes when employees are stuck with higher costs for life — and employers may be left answering for it.

Spoiler Alert: Employers Can’t Really Do Them Alone

Need to know if your plan is creditable under Part D?

This tool is designed to give employers and advisors a simple way to test prescription drug coverage against Medicare’s standard. Just enter the required values and the calculator will estimate whether your plan is likely to meet CMS’s creditable coverage standard. While this tool is a helpful guide, always confirm results with your carrier, TPA, or actuary before issuing official notices.

The $2,000 out-of-pocket cap on Medicare Part D is reshaping the program — and employer compliance along with it.

A plan that was creditable yesterday may not be tomorrow. By 2027, the old 60% shortcut disappears, and the 72% actuarial test becomes the standard. That means employers will need plan-paid vs. member-paid claims data, which only carriers or actuaries can provide.

While some carriers have been reluctant to help, that may change.

Since employers can’t realistically run these calculations themselves, carriers are the logical source — and it’s easier for them to provide determinations than to field thousands of claims data requests. Still, employers remain responsible for sending the employee notice and reporting creditable coverage status to CMS. Even if carriers supply the determination, employers must ensure notices are distributed on time and the CMS disclosure is filed.

Some employers may choose to handle this in-house, but many will prefer to outsource it.

They already rely on TPAs for COBRA, HIPAA, and other notice and reporting requirements. Part D notices and reporting should be no different. Confirming who — carrier, broker, TPA, or compliance vendor — is accountable for each step is the best safeguard against penalties and employee disputes.

For advisors, this is a chance to demonstrate real value.

Your role isn’t to crunch the numbers, but to make sure the determinations are secured, notices are sent, reports are filed, and documentation is retained.

In short:

The math has changed, the compliance bar has moved, and standing still isn’t an option. Employers, employees, and advisors alike must adapt to a Part D environment that is more generous in benefits — but far more complex to navigate.

How does the new 72% test relate to the $2,000 cap on Part D plans?

The Inflation Reduction Act phases in a $2,000 annual cap on Medicare Part D out-of-pocket spending by 2025. That makes the standard Part D benefit far richer than in the past. CMS responded by adjusting the benchmark: instead of requiring plans to cover at least 60% of costs, the revised simplified method requires 72%. The higher actuarial value is meant to mirror the improved Part D protection after the $2,000 cap, so employer plans can only be called “creditable” if they’re comparably generous.

Why would anyone use the harder 72% method if the 60% method is still available?

In most cases, they wouldn’t. If a plan design clearly qualifies under the existing 60% test, that’s the easier and safer route through 2026. But not all plans fit the 60% method’s rigid criteria. For example, a high-deductible plan with Rx subject to the deductible may fail the 60% checklist even if, in practice, it’s generous enough to meet or exceed Part D coverage. In those situations, an employer (or more realistically, the carrier) could try to use the 72% actuarial value method to prove the plan is creditable. That’s rare in practice, since carriers often won’t do the extra work unless absolutely necessary. By 2027, though, everyone is stuck with the 72% method because CMS is retiring the 60% shortcut.

Why are these called “simplified methods” when they’re so difficult?

“Simple” is a relative term. Compared to commissioning a full actuarial equivalence test, these methods are designed to be quicker: they provide a checklist (60% method) or a straightforward fraction (72% method) instead of complex actuarial modeling. But in practice, the “simplified” methods still require claims and plan-paid data that only carriers or actuaries have. That’s why they feel anything but simple to employers.

Do employers have to repeat the process for every plan they offer?

Yes. Each plan option (for example, six different medical/Rx plan designs under one employer) must have its own creditable coverage determination. That’s why most employers depend on the carrier to issue a blanket determination for every plan they sell.

What if the employer changes plans mid-year?

If the change affects creditable coverage status, the employer must issue a new notice at the time of the change. For example, if a creditable plan is replaced by a non-creditable plan effective October 1, the employer has to send another notice then—even if they already sent the annual notice by October 15.

What happens if the employer hasn’t renewed yet by October 15?

The notice is based on the current plan in effect as of October 15. If the employer later renews into a plan that is non-creditable, they must issue a second notice at that time.

What if the carrier won’t provide a determination?

CMS still holds the employer responsible. If the carrier refuses, the only safe alternative is to pay an actuary or TPA to run the analysis. Employers shouldn’t guess—the risk of getting it wrong is too high.